The purpose of this study is to compare the effect of standard care, versus standard of care
plus antimicrobial therapy (co-trimoxazole or doxycycline), on clinical outcomes in patients
diagnosed with idiopathic pulmonary fibrosis (IPF).
Phase:
Phase 3
Details
Lead Sponsor:
Weill Medical College of Cornell University
Collaborators:
Duke Clinical Research Institute National Heart, Lung, and Blood Institute (NHLBI) University of Chicago University of Pittsburgh University of Washington
Treatments:
Anti-Bacterial Agents Anti-Infective Agents Doxycycline Trimethoprim, Sulfamethoxazole Drug Combination